Brief: EQL Pharma April-June EBITDA At SEK 0.9 Million

EQL Pharma AB

22/08/2018 12:35

Aug 22 (Reuters) - EQL Pharma AB  EQL.TE :
    * CONSOLIDATED SALES FOR Q1 AMOUNTED TO SEK 10.7 (6.7) MILLION
    * APRIL-JUNE EBITDA SEK 0.9 (0.1) MILLION
    * CONTINUES TO RETAIN ITS TARGET OF GROWING AT LEAST 30% ON AVERAGE PER ANNUM OVER THE 5-
YEAR
PERIOD 2016 TO 2020/2021
    * ESTIMATE THAT SALES FOR 2018/2019 WILL BE MORE THAN 30% HIGHER THAN FOR COMPARABLE PERIOD
APRIL
2017 – MARCH 2018
    * EXPECT A RESULT JUST ABOVE THE ZERO LINE FOR THE CURRENT FISCAL YEAR

Source text for Eikon:  ID:nWkr9PB5hv 
Further company coverage:  EQL.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))